CNTX - Company ID 0001842952
Context Therapeutics Inc. trades as CNTX. This page tracks Context Therapeutics Inc. through 290 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-14 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| SCHEDULE 13G/A | - | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-08 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-01 |
The largest companies sharing Context Therapeutics Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Context Therapeutics Inc. reported a net loss of $36.12M.